glp-1 drugs competitive intelligence 2025 Market Size, Share GLP-1R Race in 2025: 8

(2021) of the CVOTs found that the GLP-1 RAs are associated with a significant 14% relative risk reduction in terms of major adverse cardiovascular events (MACE, a standard 3-component composite endpoint) (hazard ratio [HR] 0.86

Sensitivity analysis was not performed in some outcomes because of the small number of studies remaining (NAS), and there were no studies with a high risk of bias (NASH resolution, liver fat contents by CAP)

This is particularly relevant as emerging research suggests that the gut microbiome plays a critical role in regulating body weight

The majority of physicians have been in practice for more than 10 years: 13 percent practiced for fewer than 10 years, while 40 percent practiced for 10 to 19 years, 34 percent for 20 to 29 years, and 12 percent for more than 30 years

Alternative Treatment Options The Bottom Line How do medications like Ozempic work

GLP-1 side effects are most intense when increasing your dose or starting the medication, and even though youre transitioning between medications, youre technically starting one for the first time